Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Suhad Bani Melhim"'
Autor:
Abdelrahim Alqudah, Esam Y. Qnais, Mohammed A. Wedyan, Sara Altaber, Yousra Bseiso, Muna Oqal, Rawan AbuDalo, Khaled Alrosan, Amjad Z. Alrosan, Suhad Bani Melhim, Mohammad Alqudah, Rabaa Y. Athamneh, Omar Gammouh
Publikováno v:
Molecules, Vol 28, Iss 2, p 502 (2023)
Background: Isorhamnetin is a flavonoid that is found in medical plants. Several studies showed that isorhamnetin has anti-inflammatory and anti-obesity effects. This study aims to investigate the anti-diabetic effects of isorhamnetin in a high-fat d
Externí odkaz:
https://doaj.org/article/018580e7d86341aea1af1e879637c138
Autor:
Suhad Bani Melhim, Mohammad Saleh
Publikováno v:
Journal of chemotherapy (Florence, Italy). 31(5)
The objective of this project was to describe longitudinal change in chronic hepatitis C virologic reponse using time-to-event (TTE) analysis and to identify patient characteristics that determine the dynamics of this change. We compiled demographic,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2612b6e6e3062f6c7c5356f05ff5713a
https://pubmed.ncbi.nlm.nih.gov/31070545
https://pubmed.ncbi.nlm.nih.gov/31070545
Publikováno v:
European journal of drug metabolism and pharmacokinetics. 44(1)
Eltrombopag is a thrombopoietic growth factor that is approved for the treatment of thrombocytopenia in chronic hepatitis C virus (HCV) patients. We aimed to describe eltrombopag population pharmacokinetics in hepatitis C patients. Bayesian statistic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bcd2dcca226d0da68b83184f7942e7a
https://pubmed.ncbi.nlm.nih.gov/29948848
https://pubmed.ncbi.nlm.nih.gov/29948848